Plain-English translation of NCT04472338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The PATROL study is collecting blood, urine, and tissue samples from men who carry genetic changes that increase their risk of developing aggressive prostate cancer. Researchers will monitor these samples over three years to better understand who is most likely to develop the disease and to improve screening methods for men like you.
Some men inherit genetic changes that make them much more likely to develop aggressive prostate cancer. This study exists to help doctors identify which men with these genetic changes need closer monitoring and earlier screening, potentially catching prostate cancer before it becomes dangerous.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic to provide blood, urine, or tissue samples about once per year for up to three years. You may also provide additional samples if you undergo a prostate biopsy or receive treatment during the study. After any cancer treatment, you may provide one more sample about three to nine months later. The study team will track your samples to look for patterns that help identify aggressive disease.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States